Search Within

Michael David Offin

  1. "Department of Pathology and Laboratory Medicine"
Formats
  1. Meeting Abstract (57)
  2. Journal Article (50)
  3. Editorial (2)
  4. Correspondence (1)
  5. Review (1)
Groups
  1. Department of Medicine (111)
  2. Department of Pathology and Laboratory Medicine (111)
  3. Solid Tumor Oncology Division (111)
  4. Thoracic Oncology (111)
  5. Weinberg Fellows (111)
  6. GSK Faculty (93)

More Groups

People
  1. Marc Ladanyi (57)
  2. Charles Rudin (56)
  3. Mark Kris (47)
  4. Alexander Drilon (45)
  5. Bob Li (43)
  6. Maria Arcila (42)

More People

Years
  1. 2025 (3)
  2. 2024 (15)
  3. 2023 (8)
  4. 2022 (14)
  5. 2021 (23)
  6. 2020 (9)

More Years

Publications
  1. Journal of Thoracic Oncology (23)
  2. Journal of Clinical Oncology (21)
  3. Clinical Cancer Research (12)
  4. Modern Pathology (8)
  5. JCO Precision Oncology (6)
  6. Laboratory Investigation (6)

More Publications

Publishers
  1. American Society of Clinical Oncology (27)
  2. Elsevier Inc. (27)
  3. American Association for Cancer Research (20)
  4. Nature Publishing Group (8)
  5. Nature Research (8)
  6. Oxford University Press (5)

More Publishers

Results (111)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Acquired BRAF rearrangements induce secondary resistance to EGFR therapy in EGFR-mutated lung cancers
    Journal Article

    Vojnic, M.; Kubota, D.; Kurzatkowski, C.; Offin, M.; Suzawa, K.; Benayed, R.; Schoenfeld, A. J.; Plodkowski, A. J.; Poirier, J. T.; Rudin, C. M.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Tumor mutation burden and efficacy of EGFR-tyrosine kinase inhibitors in patients with EGFR-mutant lung cancers
    Journal Article

    Offin, M.; Rizvi, H.; Tenet, M.; Ni, A.; Sanchez-Vega, F.; Li, B. T.; Drilon, A.; Kris, M. G.; Rudin, C. M.; Schultz, N.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Activation of KRAS mediates resistance to targeted therapy in MET exon 14–mutant non–small cell lung cancer
    Journal Article

    Suzawa, K.; Offin, M.; Lu, D.; Kurzatkowski, C.; Vojnic, M.; Smith, R. S.; Sabari, J. K.; Tai, H.; Mattar, M.; Khodos, I.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • RET-rearranged lung cancers: Immunophenotype and response to immunotherapy
    Meeting Abstract

    Sabari, J. K.; Offin, M. D.; Wu, S. L.; Ni, A.; Halpenny, D.; Montecalvo, J.; Liu, D.; Pak, T. K.; Arbour, K. C.; Lai, W. C. V.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Circulating tumor DNA in advanced lung cancers: A prospective evaluation of matched therapy and shedding detection
    Meeting Abstract

    Offin, M. D.; Stephens, D.; Sabari, J. K.; Makhnin, A.; Myers, M.; Ni, A.; Pavlakis, N.; Clarke, S. J.; Tandon, N.; Datta, S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • In vitro functional analysis of HER2 variants in lung cancers to evaluate their oncogenic activity and predict response to HER2-targeted therapy
    Meeting Abstract

    Liu, D.; Offin, M. D.; Olah, Z. T.; Tarcic, G.; Zelichov, O.; Vidne, M.; Drilon, A. E.; Arcila, M. E.; Li, B. T.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • A multi-histology basket trial of ado-trastuzumab emtansine in patients with HER2 amplified cancers
    Meeting Abstract

    Li, B. T.; Makker, V.; Buonocore, D. J.; Offin, M. D.; Olah, Z. T.; Panora, E.; Shen, R.; Ho, A. L.; Yaeger, R.; Iyer, G.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Frequency of brain metastases and outcomes in patients with HER2-, KRAS-, and EGFR-mutant lung cancers
    Meeting Abstract

    Kris, M. G.; Offin, M. D.; Feldman, D. L.; Ni, A.; Lai, W. C. V.; Arbour, K. C.; Daras, M.; Pentsova, E.; DeAngelis, L. M.; Beal, K.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • PD-L1 expression, tumor mutation burden and response to immune checkpoint blockade in patients with HER2-mutant lung cancers
    Meeting Abstract

    Lai, W. C. V.; Feldman, D. L.; Buonocore, D. J.; Brzostowski, E. B.; Rizvi, H.; Plodkowski, A. J.; Ni, A.; Sabari, J. K.; Offin, M. D.; Kris, M. G.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Comprehensive detection of targetable fusions in lung adenocarcinomas by complementary targeted DNAseq and RNAseq assays
    Meeting Abstract

    Benayed, R.; Offin, M. D.; Mullaney, K. A.; Sukhadia, P.; Rios, K. M.; Desmeules, P.; Chang, J. C.; Hyman, D. M.; Berger, M. F.; Zehir, A.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save